Article Information
PubMed
Print ISSN
Online ISSN
History
- Received November 12, 2018
- Accepted January 28, 2019
- Published online August 23, 2019.
Article Versions
- Earlier version (February 8, 2019 - 07:07).
- You are viewing the most recent version of this article.
Copyright & Usage
Copyright © 2019 by The American Society for Pharmacology and Experimental Therapeutics
Author Information
- Bruna Corradetti,
- Simone Pisano,
- Robert Steven Conlan, and
- Mauro Ferrari
- Department of Nanomedicine, Houston Methodist Research Institute, Houston, Texas (B.C., S.P., R.S.C., M.F.); Swansea University Medical School, Singleton Park, Swansea, United Kingdom (B.C., S.P., R.S.C.); and Department of Medicine, Weill Cornell Medical College, New York, New York (M.F.)
- Address correspondence to:
Dr. Bruna Corradetti, Department of Nanomedicine, Houston Methodist Research Institute, 6670 Berner Avenue, Houston, TX 77030. E-mail: bcorradetti2{at}houstonmethodist.org
Statistics from Altmetric.com
Article usage
In this issue
Jump to section
- Article
- Abstract
- Introduction
- Immunotherapy and Cancer
- Ovarian Cancer: A “Cold” Enemy
- Nanomedicines and Immunotherapy in Ovarian Cancer
- Physical and Biologic Barriers Challenging the Treatment of OC
- Exosomes: An Alternative Tunable and Nanoscopic Strategy
- Conclusions and Perspectives
- Acknowledgments
- Authorship Contributions
- Footnotes
- Abbreviations
- References
- Figures & Data
- Info & Metrics
- eLetters
Related Articles
Cited By...
More in this TOC Section
Similar Articles
Advertisement